Drug details

Idacio (adalimumab-aacf injection)

type of DMARDs, TNF Inhibitors

Idacio (adalimumab-aacf) is a tumor necrosis factor (TNF) blocker indicated for reducing signs and symptoms of rheumatoid arthritis (RA), inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA; reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients 2 years of age and older; reducing signs and symptoms of psoriatic arthritis (PsA), inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA; reducing signs and symptoms of ankylosing spondylitis (AS) in adult patients with active AS; treatment of moderately to severely active Crohn’s disease (CD) in adults and pediatric patients 6 years of age and older; treatment of moderately to severely active ulcerative colitis (UC) in adult patients; and for treatment of adult patients with moderate to severe chronic plaque psoriasis (Ps) who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.

The drug is often used to treat Ankylosing spondylitis , Arthritis , Psoriatic arthritis , Ulcerative colitis .

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • loss of appetite,
  • dark urine,
  • vomiting,
  • fever,
  • swollen glands,
  • night sweats,
  • joint and muscle pain,
  • skin rash,
  • easy bruising,
  • unusual bleeding,
  • pale skin,
  • lightheadedness,
  • shortness of breath,
  • cold hands and feet,
  • pain in your upper stomach that may spread to your shoulder,
  • feeling full after eating only a small amount,
  • weight loss,
  • new or worsening psoriasis (raised, silvery flaking of the skin),
  • confusion,
  • chills,
  • severe drowsiness,
  • fast heartbeats,
  • rapid breathing,
  • body aches,
  • tiredness,
  • stomach pain,
  • clay-colored stools,
  • yellowing of the skin or eyes (jaundice),
  • joint pain or swelling,
  • chest pain,
  • patchy skin color that worsens in sunlight,
  • dizziness,
  • vision problems,
  • weakness in your arms or legs, and
  • fever with ongoing cough
  • right-sided upper stomach pain,
  • feeling unwell,
  • numbness or tingling,
  • sore or pump on your skin that does not heal,
The following drugs are related to Idacio, either as a replacement or used together:
  • Humira (adalimumab injection solution for subcutaneous administration)
  • Arava (leflunomide)
  • Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
  • Cimzia (certolizumab pegol injection)
  • Enbrel (etanercept)
  • Simponi Aria (golimumab for infusion)
  • Simponi Injection (golimumab injection)
  • Plaquenil (hydroxychloroquine)
  • Remicade (infliximab)
  • Trexall (methotrexate)
  • Rheumatrex (methotrexate tablets)
  • Xeljanz (tofacitinib tablets)